Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Context Therapeutics Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/17/2021 |
4/A
| Lehr Martin A. (CEO) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Converted 210,715 shares
@ $0
Converted 586,475 shares
@ $0
Bought 10,000 shares
@ $5, valued at
$50k
Exercised (out-of-the-money) 52,680 warrants
@ $7.14, valued at
$376.1k
Converted 210,715 preferred shares
@ $0
Converted 586,475 options to buy
@ $0 |
|
| 12/17/2021 |
4/A
| Dick Evan G. (SVP of R&D) has filed a Form 4 on Context Therapeutics Inc.|
Txns:
| Converted 26,587 shares
@ $0
Converted 26,587 options to buy
@ $0 |
|
|
|